Trials / Terminated
TerminatedNCT05813899
Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Mackay Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate whether probiotics PS23 can improve the symptoms of patients with long COVID-19 ; also to evaluate the effects on blood cortisol and inflammation-related indicators in patients.
Detailed description
It is expected that a total of 120 subjects will be recruited within 3 years after IRB approval, divided into two groups of 60 subjects, respectively consuming PS23 heat-treated bacteria or placebo, and completing the 6-week period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | PS23 heat-treated | PS23 heat-treated, 2 caps daily use |
Timeline
- Start date
- 2023-01-16
- Primary completion
- 2023-12-31
- Completion
- 2024-04-30
- First posted
- 2023-04-14
- Last updated
- 2024-08-15
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05813899. Inclusion in this directory is not an endorsement.